Seizinger Bernd R. 4
4 · ONCOLYTICS BIOTECH INC · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Seizinger Bernd R.
Director
Transactions
- Purchase
Common Shares
[F1]2026-01-16$1.04/sh+100,000$103,770→ 466,991 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0294 to $1.0499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Signature
/s/ Kirk Look, Attorney-in-Fact|2026-01-20